News Related to PharmaCorp Pty Ltd

Related coverage linked through entity extraction aliases.

AstraZeneca Secures Injunction Blocking Pharmacor's Generic Diabetes Drug Launch in Australia

Mar 10, 2026

AstraZeneca won a Federal Court injunction blocking Pharmacor from selling generic dapagliflozin products in Australia until a full patent trial. The patent expires October 22, 2027.

AstraZeneca Wins Injunction Blocking Generic Dapagliflozin Launch in Australia

Mar 02, 2026

The Federal Court of Australia granted AstraZeneca an interlocutory injunction on 16 February 2026 preventing Pharmacor from launching generic dapagliflozin products pending infringement proceedings, marking the second such injunction in three months.